Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
Hospital of the University of Pennsylvania
Filadelfia, Estados UnidosPublications en collaboration avec des chercheurs de Hospital of the University of Pennsylvania (1)
2022
-
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268